Login / Signup

Denosumab After Teriparatide in Premenopausal Women with Idiopathic Osteoporosis.

Elizabeth ShaneStephanie ShiauRobert R ReckerJoan M LappeSanchita AgarwalMafo Kamanda-KossehMariana BucovskyJulie StubbyAdi Cohen
Published in: The Journal of clinical endocrinology and metabolism (2021)
These data support the use of sequential teriparatide and denosumab to increase BMD in premenopausal women with severe osteoporosis.
Keyphrases
  • bone mineral density
  • postmenopausal women
  • electronic health record
  • early onset
  • big data
  • body composition
  • data analysis
  • drug induced